Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nrf2 Activator (Chlorophyllin) or Placebo With Standard Treatment for Late Radiation-induced Luminal Gastrointestinal Tract Bleeding: Multicentric Double-Blinded Phase III Randomised Trial

NCT07837713 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT07837713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07837713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nrf2 Activator (Chlorophyllin) or Placebo With Standard Treatment for Late Radiation-induced Luminal Gastrointestinal Tract Bleeding: Multicentric Double-Blinded Phase III Randomised Trial
Lead sponsor
Tata Memorial Centre
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
September 1, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal hemorrhage, radiation injuries, radiation proctitis